Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

TRIAMTERENE AND HYDROCHLOROTHIAZIDE

HYDROCHLOROTHIAZIDE; TRIAMTERENE

Standard Dose
25MG;37.5MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview TRIAMTERENE AND HYDROCHLOROTHIAZIDE is listed in Drugs@FDA under application 214611 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient HYDROCHLOROTHIAZIDE; TRIAMTERENE Form and strength CAPSULE;ORAL - 25MG;37.5MG Sponsor MACLEODS PHARMS LTD Submission history Latest submission status date: 2025-01-28 00:00:00.

Structured Monograph

Clinical summary

Approval overview TRIAMTERENE AND HYDROCHLOROTHIAZIDE is listed in Drugs@FDA under application 214611 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient HYDROCHLOROTHIAZIDE; TRIAMTERENE Form and strength CAPSULE;ORAL - 25MG;37.5MG Sponsor MACLEODS PHARMS LTD Submission history Latest submission status date: 2025-01-28 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.